Result of AGM

Assura PLC

04 July 2024

 

4 July 2024

Assura plc ("Company")

Result of AGM

Assura plc announces that at its Annual General Meeting held earlier today, each of the resolutions submitted to the meeting (as set out in the Notice of the Meeting dated 1 June 2024) were passed by the requisite majorities on a poll.

Resolution	For	% For	Against	% Against	Total Votes Cast (% of issued share capital)	Votes Withheld
1. To receive the Company's report and accounts	2,504,731,758	99.96	1,068,179	0.04	2,505,799,937 (83.82)	1,786,565
2. To approve the Directors' Remuneration Report	2,265,917,896	92.18	192,146,274	7.82	2,458,064,170 (82.22)	49,522,332
3. To re-appoint Ernst & Young LLP as auditor of the Company	2,485,635,180	99.13	21,927,079	0.87	2,507,562,259 (83.88)	24,243
4. To authorise the Audit Committee to determine the auditor's remuneration	2,507,429,142	99.99	143,591	0.01	2,507,572,733 (83.88)	13,769
5. To re-elect Ed Smith as a Director of the Company	2,334,664,222	93.55	160,936,695	6.45	2,495,600,917 (83.48)	11,985,584
6. To re-elect Louise Fowler as a Director of the Company	2,474,236,435	98.67	33,322,682	1.33	2,507,559,117 (83.88)	27,384
7. To re-elect Jonathan Murphy as a Director of the Company	2,488,262,988	99.23	19,297,044	0.77	2,507,560,032 (83.88)	26,470
8. To re-elect Jayne Cottam as a Director of the Company	2,485,494,253	99.12	22,065,779	0.88	2,507,560,032 (83.88)	26,470
9. To re-elect Jonathan Davies as a Director of the Company	2,456,425,207	98.69	32,559,286	1.31	2,488,984,493 (83.26)	18,602,008
10. To re-elect Sam Barrell as a Director of the Company	2,465,369,797	98.32	42,189,320	1.68	2,507,559,117 (83.88)	27,384
11. To re-elect Emma Cariaga as a Director of the Company	2,506,913,031	99.97	646,087	0.03	2,507,559,118 (83.88)	27,384
12. To re-elect Noel Gordon as a Director of the Company	2,493,543,158	99.44	14,019,160	0.56	2,507,562,318 (83.88)	24,184
13. To authorise the Directors to allot shares	2,389,749,564	95.30	117,821,821	4.70	2,507,571,385 (83.88)	15,117
14. To empower the Directors to disapply pre-emption rights	2,446,423,969	97.60	60,167,285	2.40	2,506,591,254 (83.85)	995,248
15. To empower the Directors to disapply pre-emption rights in connection with an acquisition or specified capital investment	2,326,633,121	93.05	173,780,257	6.95	2,500,413,378 (83.64)	7,173,124
16. To authorise the market purchase of the Company's own shares	2,488,128,029	99.24	19,017,274	0.76	2,507,145,303 (83.87)	441,199
17. To authorise the Company to call any general meeting, other than the Annual General Meeting, by not less than 14 clear days' notice	2,380,425,249	94.93	127,129,789	5.07	2,507,555,038 (83.88)	31,464
18. To amend the Articles of Association with the addition of article 91	2,504,773,882	99.98	417,429	0.02	2,505,191,311 (83.80)	2,395,191

Resolutions 1-13 were passed as ordinary resolutions. Resolutions 14-18 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman. 

Notes:

1. The percentages above are rounded to two decimal places.

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

3. The number of ordinary shares in issue on the share register at 6.00pm on 3 July 2024 was 2,989,454,390 of which the Total Voting Rights figure was 2,989,454,390.

Copies of resolutions 14-18, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

- Ends -

For more information, please contact:

Assura plc	Tel: [phone]
Orla Ball, General Counsel David Purcell, Investor Relations Director	Email: [e-mail]
FGS Global Gordon Simpson Grace Whelan	Tel: [phone] Email: [e-mail]

Notes to Editors

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

Assura plc LEI code: 21380026T19N2Y52XF72

 

END